Dynamic Technology Lab’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
TCM
ACM
CC
RCM
PBA
OM
WP
Dynamic Technology Lab's EDIT Position: Q2 2026 in Review
Dynamic Technology Lab sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 14,044 shares — an estimated $34.7K sold.
Dynamic Technology Lab first reported a position in EDIT in Q1 2017 and held it in 11 quarters. The position peaked at $630K in Q3 2022. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- Dynamic Technology Lab reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
- Dynamic Technology Lab sold 14,044 Editas Medicine shares in Q2 2026, an estimated $34.7K.
- Dynamic Technology Lab first reported a position in Editas Medicine in Q1 2017 and held it in 11 quarters.
- Dynamic Technology Lab's Editas Medicine position peaked at $630K in Q3 2022.
- 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.